-BioMap’s AI drug discovery platform integrates foundational large language models and super-scale computing with cutting-edge biotechnology to discover novel targets and design biologics through a ...

BioMAP® assays are human primary cell-based assays that read out a unique signature of biological activity for every active compound including both drug candidates and a wide range of chemicals. Using ...

Sanofi has assembled a stable of partnerships to carry out its goal of using artificial intelligence to bolster drug discovery, but those pacts mainly cover small molecule drugs. The pharmaceutical ...

Biomap, a biotechnology start-up co-established by Baidu founder Robin Li Yanhong and backed by the Hong Kong government, says it has surpassed Alphabet subsidiary AlphaFold in commercialising ...

Hong Kong, SAR--(Newsfile Corp. - June 24, 2024) - Hong Kong Science Park Corporation (HKSTP) congratulates BioMap, a Park company, on its strategic partnership with the Hong Kong Investment ...

New AI leaderboard provides comparison of 25+ of the most important, representative and cutting-edge tasks across six distinct protein design categories BioMap’s "xTrimo" 100B-parameter cross-modal ...

Robotic equipment at the UCSC Chemical Screening Center was used to screen natural product extracts for novel antibiotics. Researchers at the University of California, Santa Cruz, have developed a new ...

HONG KONG SAR - Media OutReach Newswire - 24 June 2024 - Hong Kong Science Park Corporation (HKSTP) congratulates BioMap, a Park company, on its strategic partnership with the Hong Kong Investment ...

Researchers have developed a new strategy for finding novel antibiotic compounds, using a diagnostic panel of bacterial strains for screening chemical extracts from natural sources. Researchers at the ...

Researchers at the University of California, Santa Cruz, have developed a new strategy for finding novel antibiotic compounds, using a diagnostic panel of bacterial strains for screening chemical ...